Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FL1L9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,829
Award facts
- Contract value 100% obligated
- $20,829.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On June 26, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $20,829.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The order is scheduled for completion by July 18, 2025, and carries firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and effective through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has maintained a substantial federal contract portfolio with the DLA since its SAM.gov registration in 2001, specializing in the distribution of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military health facilities. Nexplanon implants, a subdermal contraceptive device, represent one component of the company's extensive pharmaceutical offerings under its IDC, which encompasses products ranging from specialty oncology treatments to vaccines and injections. The contractor's consistent ability to secure federal contracts without set-aside designations reflects its competitive positioning as a woman-owned small business within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FL1L9?
SPE2DB25FL1L9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 26, 2025.
How much is contract SPE2DB25FL1L9 worth?
The government has obligated $20,829 on SPE2DB25FL1L9.
Is contract SPE2DB25FL1L9 an order under another contract?
Yes. SPE2DB25FL1L9 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1L9 competed?
The extent of competition for SPE2DB25FL1L9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award